Fenmoor is moving two antibody programmes into Phase II. The Head of Clinical Operations will build the team and vendor model that runs both studies across eight European sites.
What you will do
- Own study start-up, site selection and enrolment plans for two Phase II trials
- Select and manage CROs and specialist vendors against budget and timelines
- Build a clinical operations team of four over the first year
- Report trial progress to the executive team and the board
What you will bring
- Ten or more years in clinical operations, including Phase II delivery
- Experience leading CRO relationships in a small or mid-sized biotech
- Working knowledge of ICH-GCP and EU Clinical Trials Regulation
- Comfortable as the first senior hire in a growing function
What is offered
- Equity in a clinical-stage company
- Three days a week in Cambridge
- Private medical cover
- Learning budget of £3,000 a year
How you will be assessed
Every candidate for this role is assessed on the same four criteria, by the consultant and by the hiring team:
- Phase II delivery
- Has run a Phase II study from start-up to last patient out
- Vendor management
- Selects and holds CROs to budget and timelines
- Team building
- Has hired and led a clinical operations team
- Executive reporting
- Explains trial risk clearly to a board